Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
8.95
0.00 (0.00%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Burning Rock Biotech Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 514.43 | 539.57 | 515.82 | 537.44 | 563.24 | 507.86 |
Revenue Growth | -1.69% | 4.60% | -4.02% | -4.58% | 10.90% | 18.13% |
Gross Profit Gross Profit Growth | 383.52 | 402.91 | 362.4 | 363.23 | 380.04 | 364.15 |
Operating Income Operating Income Growth | -58.51 | -54.85 | -357.56 | -669.32 | -980.41 | -797.06 |
Net Income Net Income Growth | -59.32 | -55.35 | -346.63 | -653.69 | -971.23 | -796.7 |
Earnings Per Share EPS Growth | -5.70 | -5.20 | -33.70 | -63.80 | -93.50 | -76.50 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Central Laboratory Channel Central Laboratory Channel Growth | 154.12 | 159.99 | 175.65 | 232.81 | 314.77 | 319.35 |
In-Hospital Channel In-Hospital Channel Growth | 219.11 | 224.04 | 224.49 | 188.7 | 175.3 | 165.12 |
Pharma Research and Development Channel Pharma Research and Development Channel Growth | 141.2 | 155.54 | 115.68 | 115.92 | 73.17 | 23.39 |
Total Total Growth | 514.43 | 539.57 | 515.82 | 537.44 | 563.24 | 507.86 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 446 | 478.39 | 519.85 | 615.1 | 905.45 | 1,495 |
Total Debt Total Debt Growth | 50.86 | 43.12 | 52.32 | 12.32 | 50.79 | 86.69 |
Net Cash (Debt) Net Cash Growth | 395.14 | 435.27 | 467.53 | 602.77 | 854.66 | 1,408 |
Net Cash Growth | -12.74% | -6.90% | -22.44% | -29.47% | -39.32% | -36.29% |
Net Cash Per Share Net Cash Per Share Growth | 38.71 | 41.38 | 43.44 | 58.84 | 83.27 | 133.99 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -34.22 | -28.44 | -92.26 | -255.78 | -456.81 | -477.89 |
Capital Expenditures CapEx Growth | - | -5.25 | -5.42 | -8.1 | -70.29 | -210.92 |
Free Cash Flow Free Cash Flow Growth | -34.22 | -33.69 | -97.68 | -263.89 | -527.1 | -688.81 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 74.55% | 74.67% | 70.26% | 67.59% | 67.47% | 71.70% |
Operating Margin | -11.37% | -10.16% | -69.32% | -124.54% | -174.07% | -156.94% |
Pretax Margin | -11.23% | -9.97% | -66.06% | -121.19% | -172.08% | -156.70% |
Profit Margin | -11.53% | -10.26% | -67.20% | -121.63% | -172.44% | -156.87% |
FCF Margin | -6.65% | -6.24% | -18.94% | -49.10% | -93.58% | -135.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 1.27 | 2.75 | 1.03 | 1.25 | 2.83 | 125.36 |